Latest Breaking News On - ப்லஸ் சோதனை - Page 1 : comparemela.com

IDEXX Laboratories Announces First Quarter Results News provided by Share this article WESTBROOK, Maine, May 4, 2021 /PRNewswire/ Achieves reported revenue growth of 24% and organic growth of 21%, driven by CAG Diagnostics recurring revenue growth of 27% as reported and 23% organic Delivers EPS of $2.35, representing 82% growth as reported and 73% on a comparable basis Increases 2021 revenue guidance to $3,105 million - $3,160 million, reflecting higher expectations for reported growth of 14.5% - 16.5% and organic growth of 13% - 15%, supported by projected CAG Diagnostics recurring revenue growth of 16% - 17.5% as reported and 14.5% - 16% organic Raises 2021 EPS outlook to $7.88 - $8.18, reflecting expectations for 1.5% higher organic revenue growth and targeted operating margin improvement of 270 - 320 basis points as reported and 150 - 200 basis points on a comparable basis

United statesUnited kingdomJay mazelskyCompanion animal groupCompany investor relationsService categoriesExchange commissionCompany annual report on formLaboratories incForeign currency exchange rate assumptionsCompany quarterly report on formForeign currency exchangeChief executivePlus testAsia pacificAfrican swine fever